HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 643Erstellt: 23. Oktober 2026
4-Methoxybenzylamine → 4-N-[(4-methoxyphenyl)methyl]-2-N-phenylpyridine-2,4-diamine
https://huagongshe.com/de/reaction/643
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 4-Methoxybenzylamine | HCID 75452 | — |
| Edukt | 4-chloro-N-phenylpyridin-2-amine | HCID 23458041 | — |
| Reagenz | Sodium t-butoxide | HCID 23676156 | — |
| Katalysator | Palladium (II) acetate | HCID 4144353 | — |
| Katalysator | (R)-(-)-1-[(S)-2-(Dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine;Ferrocene, 1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)-, (2R)- | HCID 144543273 | — |
| Lösungsmittel | Dimethylacetamide | HCID 31374 | — |
| Produkt | 4-N-[(4-methoxyphenyl)methyl]-2-N-phenylpyridine-2,4-diamine | HCID 101883692 | 67,69% |
Reaktionsschritte
(4-methoxyphenyl)methanamine (73.7 mg, 0.54 mmol), 4-chloro-N- phenylpyridin-2-amine (100 mg, 0.49 mmol) and sodium 2-methylpropan-2-olate (94 mg, 0.98 mmol) were suspended in DMA (2 mL) and sealed into a microwave tube. Nitrogen was bubbled through the reaction mixture for 5 minutes. (R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE (32.5 mg, 0.06 mmol) and diacetoxypalladium (8.78 mg, 0.04 mmol) were added to the reaction mixture and nitrogen was bubbled through the reaction mixture for a further 5 minutes. The reaction was heated thermally to 100 °C for 30 mins under nitrogen and cooled to RT. The reaction mixture was neutralised with HCl and purified by ion exchange chromatography, using a 20 g SCX column. The crude product was purified by flash silica chromatography, elution gradient 0 to 10% MeOH in DCM. Fractions containing product were evaporated to dryness to afford N4-(4-methoxybenzyl)-N2-phenylpyridine-2,4-diamine (101 mg, 67.7 %) as a white solid.
Herkunft & Nachweise
| Quelldatensatz | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-59c6d21cb6354f44a2ed185cff3caeb9 |
|---|
| Quellennotiz | 750 AstraZeneca ELN dataset |
|---|